Absence of the intestinal microbiota exacerbates hepatobiliary disease in a murine model of primary sclerosing cholangitis.
about
The changing faces of cholangitisThe enteric microbiome in hepatobiliary health and diseaseImpact of Microbes on the Pathogenesis of Primary Biliary Cirrhosis (PBC) and Primary Sclerosing Cholangitis (PSC)Inflammatory Bowel Disease and Primary Sclerosing Cholangitis: A Review of the Phenotype and Associated Specific Features.Primary sclerosing cholangitis is characterised by intestinal dysbiosis independent from IBDThe Microbiome and Immune Regulation After Transplantation.Role of the Intestinal Microbiome in Cholestatic Liver Disease.Evolving paradigm of treatment for autoimmune hepatitis.Emerging pharmacologic therapies for primary sclerosing cholangitis.The gut microbiome and liver cancer: mechanisms and clinical translation.Review article: next-generation transformative advances in the pathogenesis and management of autoimmune hepatitis.Does the Intestinal Microbiota Explain Differences in the Epidemiology of Liver Disease between East and West?The "gut microbiota" hypothesis in primary sclerosing cholangitis.Factoring the intestinal microbiome into the pathogenesis of autoimmune hepatitisToxic bile and sclerosing cholangitis: Is there a role for pharmacological interruption of the bile acid enterohepatic circulation?Microbiota and Alcoholic Liver Disease.Cholangiocytes and the environment in primary sclerosing cholangitis: where is the link?Knockdown of Hepatic Gonadotropin-Releasing Hormone by Vivo-Morpholino Decreases Liver Fibrosis in Multidrug Resistance Gene 2 Knockout Mice by Down-Regulation of miR-200b.Remote Sensing between Liver and Intestine: Importance of Microbial Metabolites.The gut microbiota contributes to a mouse model of spontaneous bile duct inflammation.Alterations in Intestinal Microbiota Lead to Production of Interleukin 17 by Intrahepatic γδ T-cell Receptor-positive Cells and Pathogenesis of Cholestatic Liver Disease.The gut microbiota, bile acids and their correlation in primary sclerosing cholangitis associated with inflammatory bowel disease.The microbiome and autoimmunity: a paradigm from the gut-liver axis.Paracrine cellular senescence exacerbates biliary injury and impairs regeneration.The ectonucleotidase ENTPD1/CD39 limits biliary injury and fibrosis in mouse models of sclerosing cholangitis.Gut microbiome and liver diseases.Primary sclerosing cholangitis: 50 years of a gut-liver relationship and still no love?Update on pharmacotherapies for cholestatic liver disease.Primary Sclerosing Cholangitis, Part 1: Epidemiology, Etiopathogenesis, Clinical Features, and Treatment.Discovery of glycocholic acid and taurochenodeoxycholic acid as phenotypic biomarkers in cholangiocarcinomaMucosal Autoimmunity to Cell-Bound GP2 Isoforms Is a Sensitive Marker in PSC and Associated With the Clinical Phenotype
P2860
Q26747051-7D84953F-7444-4057-9E51-2E5DBC7DC009Q26777426-B9E09402-EC37-474D-B434-5EDE8D1CCE0CQ28076453-50ADB871-1AFD-4476-9837-D7DB787C47B8Q30234950-F3AF425E-D74C-4A89-8114-1174338AC313Q36025017-CEDDD8B4-2914-44A3-8D0A-976947A67280Q36102645-271C1344-18B5-4552-B7E2-4F337D06A732Q36294233-74FCFCF2-76AC-4EE8-9387-3A24C7F62753Q38730872-4FF21D42-BAA0-487E-88B5-BE88E6119BD3Q38751076-11D4D30C-6D3C-42E2-8807-00395FF6D501Q39414187-33C69579-3A8E-49F6-8A9F-C109643ED862Q40044046-F2BE6ABF-4BD1-4B52-92C4-FC6BC85677C0Q40727491-E623D63F-8633-4830-8105-B20E88254036Q42330826-172C19BE-A5B7-42A8-A994-056DDBFC3FCDQ42369219-C18300F8-2CEF-4E75-B1FF-F88F5A23F11FQ42686933-57553A45-1029-49D3-AFC1-4F9D866315E6Q46524927-4746B382-4E6A-4AF7-9A08-21C72D1D7A43Q47162395-C81700C1-3CFF-45F1-B6CE-DFDB516F521CQ47886786-D09F8962-7A35-41F1-9398-08E8632001ACQ49569061-8BD46D75-C149-4196-AD24-D16AF65C63B4Q49799963-4CCF2C9E-98A7-4A18-8F2E-42D8D2A125B1Q49896566-8317E411-BD5D-4CA1-8BC1-C657272B5A84Q50052495-0135F8E4-65AD-4050-BF22-C92F9481995BQ52715835-B92D8C31-CA0F-4203-8B5F-88D2E8D20972Q52727520-6ED6C06F-BB75-4857-BB1C-67468AA68B96Q52733589-D4AF9D75-A0DA-48E9-8778-0C3B8C9C2465Q52839364-A4D035B7-75E4-4987-B089-625598CDFC64Q54321179-0E766C9E-041A-4882-8CDF-68DC8AF82998Q55333522-9B3A743E-41E2-4611-B185-71F520B321A4Q55497458-A3450EFB-FB64-4FFF-9D33-8CF1EFB108EBQ57114361-3B270B27-BFEA-4E6B-B216-C87D45DF2B76Q58697836-BEF5671C-E4E2-4E7C-858B-8450D6FC7EF8
P2860
Absence of the intestinal microbiota exacerbates hepatobiliary disease in a murine model of primary sclerosing cholangitis.
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Absence of the intestinal micr ...... rimary sclerosing cholangitis.
@ast
Absence of the intestinal micr ...... rimary sclerosing cholangitis.
@en
Absence of the intestinal micr ...... rimary sclerosing cholangitis.
@nl
type
label
Absence of the intestinal micr ...... rimary sclerosing cholangitis.
@ast
Absence of the intestinal micr ...... rimary sclerosing cholangitis.
@en
Absence of the intestinal micr ...... rimary sclerosing cholangitis.
@nl
prefLabel
Absence of the intestinal micr ...... rimary sclerosing cholangitis.
@ast
Absence of the intestinal micr ...... rimary sclerosing cholangitis.
@en
Absence of the intestinal micr ...... rimary sclerosing cholangitis.
@nl
P2093
P2860
P356
P1433
P1476
Absence of the intestinal micr ...... rimary sclerosing cholangitis.
@en
P2093
Christy E Trussoni
James H Tabibian
Lee R Hagey
Nicholas F LaRusso
Pamela S Tietz
Patrick L Splinter
Steven P O'Hara
Taofic Mounajjed
P2860
P304
P356
10.1002/HEP.27927
P407
P577
2015-06-04T00:00:00Z